| Product Code: ETC6739929 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, China witnessed a steady rise in the import of cold and flu supplements, with the top exporting countries being the USA, Germany, Australia, Hong Kong, and South Korea. The market shows a healthy competition with low concentration levels indicated by the Herfindahl-Hirschman Index (HHI). The impressive compound annual growth rate (CAGR) of 12.86% from 2020 to 2024 highlights the increasing demand for these supplements. Moreover, the growth rate of 16.29% from 2023 to 2024 suggests a promising outlook for the industry, signaling opportunities for further expansion and market penetration.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Cold And Flu Supplements Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Cold And Flu Supplements Market Revenues & Volume, 2021 & 2031F |
3.3 China Cold And Flu Supplements Market - Industry Life Cycle |
3.4 China Cold And Flu Supplements Market - Porter's Five Forces |
3.5 China Cold And Flu Supplements Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 China Cold And Flu Supplements Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Cold And Flu Supplements Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing consumer awareness about preventive healthcare measures |
4.2.2 Growing demand for natural and herbal remedies |
4.2.3 Rising prevalence of cold and flu cases in China |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for supplements |
4.3.2 High competition from pharmaceutical drugs offering similar benefits |
5 China Cold And Flu Supplements Market Trends |
6 China Cold And Flu Supplements Market, By Types |
6.1 China Cold And Flu Supplements Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 China Cold And Flu Supplements Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 China Cold And Flu Supplements Market Revenues & Volume, By Vitamins & Minerals, 2021- 2031F |
6.1.4 China Cold And Flu Supplements Market Revenues & Volume, By Herbal Extracts, 2021- 2031F |
6.1.5 China Cold And Flu Supplements Market Revenues & Volume, By Natural Molecules, 2021- 2031F |
6.2 China Cold And Flu Supplements Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 China Cold And Flu Supplements Market Revenues & Volume, By Pharmacies & Drug Stores, 2021- 2031F |
6.2.3 China Cold And Flu Supplements Market Revenues & Volume, By Hypermarkets & Supermarkets, 2021- 2031F |
6.2.4 China Cold And Flu Supplements Market Revenues & Volume, By Online, 2021- 2031F |
6.2.5 China Cold And Flu Supplements Market Revenues & Volume, By Others, 2021- 2031F |
7 China Cold And Flu Supplements Market Import-Export Trade Statistics |
7.1 China Cold And Flu Supplements Market Export to Major Countries |
7.2 China Cold And Flu Supplements Market Imports from Major Countries |
8 China Cold And Flu Supplements Market Key Performance Indicators |
8.1 Consumer trust and satisfaction levels with cold and flu supplements |
8.2 Number of new product launches and innovations in the market |
8.3 Growth in distribution channels for cold and flu supplements in China |
9 China Cold And Flu Supplements Market - Opportunity Assessment |
9.1 China Cold And Flu Supplements Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 China Cold And Flu Supplements Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Cold And Flu Supplements Market - Competitive Landscape |
10.1 China Cold And Flu Supplements Market Revenue Share, By Companies, 2024 |
10.2 China Cold And Flu Supplements Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |